Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 2ER+ and AR+ Breast Cancer 2Muscular Atrophy 1Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Breast Neoplasms 1

Interventions

Megestrol Acetate 4Mirtazapine 2ostarine 1nabiximols 1clazakizumab 1anamorelin 1Sodium Chloride 1Physical Therapy Modalities 1Omacor 1Olanzapine 1Nutrition Assessment 1Megestrol 1Infliximab 1Ibuprofen 1Gemcitabine 1Flurandrenolone 1Fecal Microbiota Transplantation 1Cyproheptadine 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cachexia × ostarine × Clear all
NCT00467844 2014-07-11

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

GTx

Phase 2 Completed
159 enrolled 11 charts
GastrointestinalLymphoidThoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Muscular Atrophy, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡